Jubilant Pharmova Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
11411.70 Cr.
|
P/BV
|
2.11
|
Book Value (Rs.)
|
338.98
|
52 Week High/Low (Rs.)
|
741/319
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
Bookclosure
|
10/08/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.70
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 6219.30 | 6059.17 | 5963.88 | 5842.84 | 8997.09 |
Other Operating Revenues | 62.43 | 71.00 | 134.66 | 132.95 | 113.73 |
Total Operating Revenues | 6281.73 | 6130.16 | 6098.54 | 5975.79 | 9110.82 |
| | | | | |
Other Income | 38.33 | 11.29 | 17.64 | 37.41 | 35.74 |
Total Revenue | 6320.06 | 6141.45 | 6116.17 | 6013.20 | 9146.56 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 1666.41 | 1348.70 | 1348.75 | 1438.02 | 3282.80 |
Purchase Of Stock-In Trade | 252.22 | 201.62 | 167.63 | 154.62 | 240.91 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -40.70 | -62.32 | 19.63 | -137.46 | -1.87 |
Employee Benefit Expenses | 2166.02 | 2043.39 | 1922.88 | 1843.22 | 1925.96 |
Finance Costs | 188.20 | 145.49 | 184.10 | 199.71 | 219.81 |
Depreciation And Amortisation Expenses | 554.03 | 381.70 | 348.95 | 339.84 | 370.90 |
Other Expenses | 1461.53 | 1442.44 | 1243.18 | 1129.44 | 1924.01 |
Total Expenses | 6247.71 | 5501.02 | 5235.12 | 4967.39 | 7962.52 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 72.35 | 640.43 | 881.06 | 1045.81 | 1184.04 |
| | | | | |
Exceptional Items | -56.82 | 0.00 | -21.23 | -32.93 | -280.23 |
Profit/Loss Before Tax | 15.53 | 640.43 | 859.82 | 1012.88 | 903.81 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 181.09 | 172.55 | 269.91 | 292.11 | 282.15 |
Deferred Tax | -88.42 | 44.88 | 27.31 | 43.00 | 44.65 |
Total Tax Expenses | 92.66 | 217.43 | 297.22 | 335.10 | 326.80 |
Profit/Loss After Tax And Before ExtraOrdinary Items | -77.13 | 423.00 | 562.61 | 677.77 | 577.01 |
| | | | | |
Profit/Loss From Continuing Operations | -77.13 | 423.00 | 562.61 | 677.77 | 577.01 |
| | | | | |
Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 340.93 | 197.66 | 0.00 |
Total Tax Expenses Discontinuing Operations | 0.00 | 0.00 | 79.18 | -22.82 | 0.00 |
Net Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 261.75 | 220.47 | 0.00 |
Profit/Loss For The Period | -77.13 | 423.00 | 824.36 | 898.24 | 577.01 |
| | | | | |
Minority Interest | 3.90 | 0.92 | 0.26 | 0.00 | -2.55 |
Share Of Profit/Loss Of Associates | 12.25 | -9.98 | 11.25 | 0.00 | 0.00 |
Consolidated Profit/Loss After MI And Associates | -60.98 | 413.94 | 835.87 | 898.25 | 574.46 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | -3.83 | 26.00 | 52.48 | 56.39 | 36.86 |
Diluted EPS (Rs.) | -3.83 | 26.00 | 52.48 | 56.39 | 36.86 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 79.64 | 79.64 | 0.00 | 151.32 | 47.78 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 1.52 | 8.35 |